Phillips T, Wang M, Robak T, Gallinson D, Stevens D, Patel K, Ramadan S, Wun C-C, Jurczak W, Smith SD. Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naïve or relapsed/refractory mantle cell lymphoma: phase Ib trial. haematol [Internet]. 2025Mar.1 [cited 2025Mar.25];110(3):715-24. Available from: https://haematologica.org/article/view/haematol.2023.284896